Yi-Chieh Li

Title: Innovations by Yi-Chieh Li

Introduction

Yi-Chieh Li is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical treatments, particularly in addressing diseases associated with carbonyl stress. His innovative approach focuses on utilizing specific compounds to mitigate health issues caused by harmful accumulations in the human body.

Latest Patents

Yi-Chieh Li holds 1 patent for his invention titled "Method of treating a patient with a disease caused by a pathogenic mechanism associated with accumulation of methylglyoxal." This patent discloses a method that involves administering a monosaccharide and/or polysaccharide as an active ingredient. The goal is to decrease the accumulation of di-carbonyl compounds in the human body. The invention highlights that the monosaccharide is a monomer of the polysaccharide, with the molecular weight of the polysaccharide ranging from 29 kDa to 36 kDa. This method can be used to prevent or treat nephritis and other diseases linked to di-carbonyl compounds.

Career Highlights

Throughout his career, Yi-Chieh Li has focused on innovative solutions in the medical field. His work emphasizes the importance of addressing carbonyl stress and its implications for human health. His dedication to research and development has led to advancements that could potentially improve treatment options for various diseases.

Collaborations

Yi-Chieh Li has collaborated with fellow researcher Jen-Ai Lee. Their partnership has contributed to the development of innovative methods and treatments in the medical field.

Conclusion

Yi-Chieh Li's contributions to medical innovation demonstrate the potential for new treatments that address complex health issues. His work continues to inspire advancements in the field of medicine.